Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other CancersThomas M. Cardillo, David M. Goldenberg, Robert M. Sharkey et al.|Bioconjugate Chemistry|2015Cited by 302
Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T CellsChien‐Hsing Chang, David M. Goldenberg, Thomas M. Cardillo et al.|Cancer Research|2017Cited by 83
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancerDonglin Liu, Chien‐Hsing Chang, Yang Wang et al.|Molecular Cancer|2014Cited by 33
Interferon-λ1 Linked to a Stabilized Dimer of Fab Potently Enhances both Antitumor and Antiviral Activities in Targeted CellsDonglin Liu, David M. Goldenberg, Thomas M. Cardillo et al.|PLoS ONE|2013Cited by 8
Abstract 1221: Targeting interferon-λ1 with a stabilized dimer of anti-tumor Fab .Donglin Liu, Chien‐Hsing Chang, Edmund A. Rossi et al.|Cancer Research|2013Cited by 1